Endava PLC – (DAVA) Given Average Recommendation of “Hold” by Analysts

Shares of Endava PLC – (NYSE:DAVA) have been assigned a consensus rating of “Hold” from the six analysts that are presently covering the firm, MarketBeat Ratings reports. Three research analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average twelve-month target price among brokers that have issued a report on the stock in the last year is $28.40.

A number of brokerages recently issued reports on DAVA. Credit Suisse Group began coverage on Endava in a research note on Tuesday, August 21st. They issued a “neutral” rating and a $27.00 target price for the company. Morgan Stanley began coverage on Endava in a research note on Tuesday, August 21st. They issued a “weight” rating and a $29.00 target price for the company. William Blair began coverage on Endava in a research note on Tuesday, August 21st. They issued an “outperform” rating for the company. Cowen began coverage on Endava in a research note on Tuesday, August 21st. They issued an “outperform” rating and a $27.00 target price for the company. Finally, Citigroup began coverage on Endava in a research note on Tuesday, August 21st. They issued a “neutral” rating and a $30.00 target price for the company.

Shares of DAVA stock opened at $25.87 on Friday. Endava has a 1 year low of $23.00 and a 1 year high of $30.50.

About Endava

Endava plc provides IT service to finance, insurance and healthcare, retail and consumer goods, telecommunications, media, and technology industries in the United Kingdom. It offers architecture solutions; AI and Intelligent Automation, bots and natural language interfaces, and Robotic Process Automation; software engineering; testing solutions; cloud services; and application management services.

Featured Story: Understanding Price to Earnings Ratio (PE)

Analyst Recommendations for Endava (NYSE:DAVA)

Receive News & Ratings for Endava Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endava and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply